Severe local reactions to pneumococcal vaccine

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Pneumococcal vaccines are crucial for preventing invasive pneumococcal disease.
• Understanding vaccine adverse events is essential for patient safety and vaccine efficacy.
• Atopy is a common condition associated with allergic responses.

Observation:

• Two patients presented with severe, localized pain and swelling extending beyond the injection site after receiving pneumococcal vaccine.
• Both patients had a history of atopy.
• One patient had received pneumococcal vaccine previously, while the other had extensive laboratory exposure to pneumococci.

Findings:

• The observed severe local reactions suggest a potential hypersensitivity response in atopic individuals with prior pneumococcal exposure.
• These reactions were beyond the expected local inflammatory response to vaccination.
• The findings highlight a specific risk profile for adverse events following pneumococcal vaccination.

Implications:

• Clinicians should exercise caution when considering pneumococcal revaccination in atopic patients with a history of exposure.
• Further investigation into the immunological mechanisms underlying these severe reactions is warranted.
• This underscores the importance of individualized risk assessment in vaccination protocols.